ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

COGT Cogent Biosciences Inc

6.60
0.10 (1.54%)
取引時間後
最終更新日: 06:35:17
15分遅延
名称 銘柄コード 市場 種別
Cogent Biosciences Inc COGT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.10 1.54% 6.60 06:35:17
始値 安値 高値 終値 前日終値
6.50 6.46 7.257 6.93 6.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0922:00GLOBECogent Biosciences Presents Data Highlighting Potential..
2024/2/2706:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2623:13EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2622:30EDGAR2Form 8-K - Current report
2024/2/2622:00GLOBECogent Biosciences Reports Recent Business Highlights and..
2024/2/2304:30GLOBECogent Biosciences Announces Positive Part 1b Data from..
2024/2/1708:55EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/1708:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1502:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1422:35EDGAR2Form 8-K - Current report
2024/2/1421:00GLOBECogent Biosciences Announces Oversubscribed $225 Million..
2024/2/1006:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0523:00GLOBECogent Biosciences to Present SUMMIT Part 1b Data with..
2024/1/2606:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0922:00GLOBECogent Biosciences Announces Planned 2024 Milestones for..
2024/1/0506:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0222:00GLOBECogent Biosciences Announces Presentation at the 42nd Annual..
2023/12/1122:04EDGAR2Form 8-K - Current report
2023/12/1121:55GLOBECogent Biosciences Announces Positive Data from Ongoing..
2023/12/1003:30GLOBECogent Biosciences Announces Positive Initial Data from..
2023/12/0723:00GLOBECogent Biosciences Presents New Preclinical Data..
2023/12/0422:00GLOBECogent Biosciences to Host Investor Webcast on December 11,..
2023/11/2922:00GLOBECogent Biosciences Announces Poster Presentations at..
2023/11/0721:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0222:18EDGAR2Form 8-K - Current report
2023/11/0222:00GLOBECogent Biosciences Reports Recent Business Highlights and..
2023/10/1501:30GLOBECogent Biosciences Presents Preclinical Data Highlighting..
2023/10/0405:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0905:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0821:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0821:14EDGAR2Form 8-K - Current report
2023/8/0821:00GLOBECogent Biosciences Reports Recent Business Highlights and..
2023/7/0605:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/1005:01GLOBECogent Biosciences Announces Closing of Upsized Public..
2023/6/0722:00GLOBECogent Biosciences Announces Participation in the Jefferies..
2023/6/0709:25GLOBECogent Biosciences Announces Pricing of Upsized Public..
2023/6/0705:05GLOBECogent Biosciences Announces Proposed Public Offering of..
2023/6/0403:15GLOBECogent Biosciences Announces Positive Lead-In Data from..
2023/5/2321:00GLOBECogent Biosciences to Host Investor Webcast to Discuss..
2023/5/0921:00GLOBECogent Biosciences Reports Recent Business Highlights and..

最近閲覧した銘柄

Delayed Upgrade Clock